Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle-Invasive Bladder Cancer

David D'Andrea, Peter C. Black, Homayoun Zargar, C. P. Dinney, Francesco Soria, M. S. Cookson, Jeffrey S Montgomery, Wassim Kassouf, Marc A Dall'Era, Srikala S. Sridhar, John S McGrath, Jonathan Wright, Andrew C. Thorpe, J. M. Holzbeierlein, Diego Carrión, Ettore Di Trapani, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair LotanPetros Grivas, Andrew J Stephenson, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat, Kamran Zargar-Shoshtari, Laura S Mertens, Adrian S Fairey, Maria C Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J Campain, J. A. Seah, C. E. Ercole, Simon Horenblas, J. Aning, Todd M Morgan, Jay B Shah, Marco MoschiniShow 25 moreShow less